| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
|
Kanai, Masashi
|
|
2010
|
68 |
1 |
p. 157-164
|
article
|
| 2 |
Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?
|
McIntyre, Dominick J. O.
|
|
2010
|
68 |
1 |
p. 29-36
|
article
|
| 3 |
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
|
Speeten, Kurt Van der
|
|
2010
|
68 |
1 |
p. 147-156
|
article
|
| 4 |
Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity
|
Chen, Lei
|
|
2010
|
68 |
1 |
p. 17-27
|
article
|
| 5 |
Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients
|
Specenier, P.
|
|
2010
|
68 |
1 |
p. 185-191
|
article
|
| 6 |
Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer
|
Kim, Jung A.
|
|
2010
|
68 |
1 |
p. 177-184
|
article
|
| 7 |
Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors
|
Benjamin, Robert S.
|
|
2010
|
68 |
1 |
p. 69-77
|
article
|
| 8 |
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid
|
Heinz, Werner J.
|
|
2010
|
68 |
1 |
p. 239-245
|
article
|
| 9 |
Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts
|
Stefano, Ilaria De
|
|
2010
|
68 |
1 |
p. 107-116
|
article
|
| 10 |
Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell–cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells
|
Freitas Junior, Julio Cesar Madureira de
|
|
2010
|
68 |
1 |
p. 227-238
|
article
|
| 11 |
Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice
|
Wu, Zhen-Qian
|
|
2010
|
68 |
1 |
p. 87-96
|
article
|
| 12 |
In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone
|
Magalhães, Hemerson Iury F.
|
|
2010
|
68 |
1 |
p. 45-52
|
article
|
| 13 |
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
|
Fransvea, Emilia
|
|
2010
|
68 |
1 |
p. 79-86
|
article
|
| 14 |
Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro
|
Li, Li-Hua
|
|
2010
|
68 |
1 |
p. 207-215
|
article
|
| 15 |
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
|
Xenidis, Nikolaos
|
|
2010
|
68 |
1 |
p. 63-68
|
article
|
| 16 |
Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma
|
Nagai, Hidenari
|
|
2010
|
68 |
1 |
p. 139-145
|
article
|
| 17 |
Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study
|
Muñoz-Casares, Francisco C.
|
|
2011
|
68 |
1 |
p. 267-274
|
article
|
| 18 |
Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential
|
Trojel-Hansen, Christina
|
|
2010
|
68 |
1 |
p. 127-138
|
article
|
| 19 |
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
|
Cascinu, Stefano
|
|
2010
|
68 |
1 |
p. 37-43
|
article
|
| 20 |
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
|
Brendel, Erich
|
|
2010
|
68 |
1 |
p. 53-61
|
article
|
| 21 |
Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy
|
Horimatsu, Takahiro
|
|
2011
|
68 |
1 |
p. 263-266
|
article
|
| 22 |
Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement
|
Tsimberidou, Apostolia M.
|
|
2010
|
68 |
1 |
p. 247-253
|
article
|
| 23 |
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
|
Lim, Taekyu
|
|
2011
|
68 |
1 |
p. 255-262
|
article
|
| 24 |
Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2
|
Ferdinandi, Eckhardt S.
|
|
2010
|
68 |
1 |
p. 193-205
|
article
|
| 25 |
Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study
|
Shin, Dong-Yeop
|
|
2010
|
68 |
1 |
p. 165-175
|
article
|
| 26 |
Review on clinical trials of targeted treatments in malignant mesothelioma
|
Jakobsen, Jan Nyrop
|
|
2011
|
68 |
1 |
p. 1-15
|
article
|
| 27 |
Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
|
Polyzos, Aris
|
|
2010
|
68 |
1 |
p. 217-223
|
article
|
| 28 |
Sandostatin desensitization–a strategy useful for patients with carcinoid tumors, intolerant to sandostatin
|
Vinjamaram, Sanjay
|
|
2010
|
68 |
1 |
p. 225-226
|
article
|
| 29 |
Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868
|
Jordheim, Lars Petter
|
|
2010
|
68 |
1 |
p. 97-105
|
article
|
| 30 |
Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells
|
Wilmes, Anja
|
|
2010
|
68 |
1 |
p. 117-126
|
article
|
Journal description